Article Details

Genentech's Susvimo Gets FDA Nod as Continuous Delivery Treatment for Diabetes ...

Retrieved on: 2025-02-08 09:26:05

Tags for this article:

Click the tags to see associated articles and topics

Genentech's Susvimo Gets FDA Nod as Continuous Delivery Treatment for Diabetes .... View article details on hiswai:

Summary

The article discusses FDA approval of Genentech's ranibizumab injection for diabetic macular edema (DME) and its prior approval for age-related macular degeneration (AMD). Tags like "Ranibizumab," "Macular degeneration," and "Anti-VEGF" highlight its role in ophthalmology via intravitreal administration.

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up